There is a conversation I have had more times than I can count over 35 years in life sciences. It usually happens somewhere between the tail end of a capital project and the first sign of trouble. The team is behind schedule. The pressure to get a piece of equipment or a facility online is real. And someone in the room says something along the lines of: “Can we move faster on the CQV?”

The answer, technically, is sometimes yes. But the more important answer is this: the time you save in CQV is not actually saved. You borrow it. And the interest rate on that loan is high.

What CQV Actually Is

By definition, Commissioning, Qualification, and Validation are the structured frameworks by which life sciences organizations confirm that equipment, systems, utilities, and processes perform as intended within a regulated environment. Commissioning verifies that systems are installed and functioning according to design specifications. Qualification establishes documented evidence that equipment operates consistently within defined parameters, through Installation Qualification, Operational Qualification, and Performance Qualification. Validation extends that rigor to processes, confirming that a given process reliably produces results that meet predetermined specifications.

The bottom line, though, is that CQV is how a life sciences organization demonstrates to itself, to its clients, and to regulatory authorities that it is in control of its environment and its outputs. It is not paperwork for paperwork’s sake. It is the foundation for everything else in a regulated operation.

Where Organizations Get Into Trouble

The most common mistake I see is treating CQV as a milestone to pass rather than a program to build. Teams execute protocols, generate reports, close out the binder, and move on. The equipment goes into service. The documentation goes into a file. And the organization considers the matter settled.

Until it is not.

A deviation surfaces. An audit raises a question. A piece of equipment behaves unexpectedly. And the team reaches back into the validation record looking for answers, only to find documentation completed under pressure, with gaps that seemed acceptable at the time.

The other mistake is treating CQV as something that happens once. Validation is not a permanent condition. It is a state that must be maintained. Changes to equipment, processes, facility conditions, or personnel can all affect validated status. An organization that validates once and walks away is not a validated organization. It is an organization with a validated moment in time.

The Cost of Getting It Wrong

Failed audits are the most visible consequence, but they are not the only ones. Revalidation following a deviation or an out-of-tolerance finding is expensive in time, in resources, and in the operational disruption it causes. Product holds, batch failures, and regulatory warning letters are downstream consequences of CQV programs that were under-resourced or poorly executed from the start.

But the consequences go beyond the organization. At its core, life sciences compliance exists to protect patients. A medication produced with too much active ingredient or not enough active ingredient does not just create a regulatory problem. It can cost a patient their life. That is the real stakes of getting CQV wrong, and it is the reason this work deserves to be taken seriously at every level of an organization.

Less visible but equally real is the organizational toll. When a validation program is shaky, the people running it know it. Quality teams spend too much energy managing the anxiety of that uncertainty rather than running a forward-looking, proactive compliance program. That is a cost that never shows up on a balance sheet, but it is there.

What a CQV Partnership Actually Looks Like

At Krieger, we approach CQV differently than a project vendor would. A project vendor executes protocols and delivers a binder. That has value. But it is not the same as a partner who understands your program, your equipment history, your regulatory environment, and your organizational risk tolerance, and who brings that context to every engagement.

Our CQV work begins with understanding what you are trying to accomplish and what is already in place. We write and execute protocols that reflect your actual operating conditions, not a generic template applied to your equipment. We document with the audit in mind, because that is when the documentation must hold up. And when the immediate project is complete, we do not disappear. We stay engaged, because the next change, the next piece of equipment, the next regulatory question is coming, and you should not have to start from scratch every time it does.

That ongoing relationship is where real value lives. Not in the binder, in the partnership.

The Bottom Line

CQV is not a cost center. It is not a regulatory nuisance. It is the foundation for a compliant, audit-ready, operationally sound life sciences program. Organizations that treat it as a checkbox tend to find out, eventually and usually at high cost, that the foundation was not as solid as they thought.

The ones that get it right treat CQV as a program, not a project. They resource it properly, execute it rigorously, and maintain it continuously. And they tend to sleep better before audits.

If your CQV program could use a fresh set of eyes, or if you are building one from the ground up, we would welcome the conversation.